Loading…
Further analysis of protection induced by the MIC3 DNA vaccine againstT. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection
The present study was conducted mainly to evaluate the contribution of the cellular and the humoral responses in protection conferred by the MIC3 DNA vaccine (pMIC3i) that was proved as a potent vaccine against toxoplasmosis. We performed the adoptive transfer of CD4+and CD8+T lymphocytes from pMIC3...
Saved in:
Published in: | Vaccine 2009-05, Vol.27 (22), p.2959 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 22 |
container_start_page | 2959 |
container_title | Vaccine |
container_volume | 27 |
creator | Ismael, Alaa Bassuny Hedhli, Dorsaf Cérède, Odile Lebrun, Maryse Dimier-Poisson, Isabelle Mévélec, Marie-Noëlle |
description | The present study was conducted mainly to evaluate the contribution of the cellular and the humoral responses in protection conferred by the MIC3 DNA vaccine (pMIC3i) that was proved as a potent vaccine against toxoplasmosis. We performed the adoptive transfer of CD4+and CD8+T lymphocytes from pMIC3i immunized mice to naive ones and the role of humoral immunity was evaluated byin vitroinvasion assays. We also constructed plasmids encoding the EGF-like domains and the Lectin-like domain of MIC3, to define which domains of MIC3 are involved in the protection. Furthermore, the adjuvant effect of the GM-CSF-expressing vector (granulocyte-macrophage colony-stimulating factor) required the precise temporal and spatial codelivery of GM-CSF with antigen, thus, we constructed a bicistronic plasmid expressing MIC3 and GM-CSF. In conclusion, the protection induced by pMIC3i was mainly mediated by CD4+and CD8+T lymphocytes and both EGF and Lectin domains of MIC3 conferred protection. Furthermore, the codelivery of GM-CSF by a bicistronic plasmid appeared to be a most effective way for enhancing the adjuvant properties of GM-CSF. |
doi_str_mv | 10.1016/j.vaccine.2009.02.107 |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1618887605</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3476861791</sourcerecordid><originalsourceid>FETCH-proquest_journals_16188876053</originalsourceid><addsrcrecordid>eNqNkM1OwzAQhC0EEuHnEZBW4kqCnaSJyw2lDSABpxy4Va7jtA6pDbZTqc_MS-CEIoTEgdNoV7PfjBahC4Ijgkl23UZbxrlUIooxnkY49uv8AAWE5kkYTwg9RAGOszRMCX45RifWthjjSUKmAfooe-PWwgBTrNtZaUE38Ga0E9xJrUCquueihuUOvA2eHooEZs-3sE8EtmJSWVdFsNKqlvIGilnqYbVXChVw0XUWmBHj-Ya12oBoGk_XZsz6ixp-p_4UuYKldmt4HCYVdvJVjCHzu_JrqPVmKDIQRxrXqhHG_GKcoaOGdVac7_UUXZbzqrgPveW9F9YtWt0b_we7IBmhlOaZ_9L_XJ8OG3xT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1618887605</pqid></control><display><type>article</type><title>Further analysis of protection induced by the MIC3 DNA vaccine againstT. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection</title><source>ScienceDirect Freedom Collection</source><creator>Ismael, Alaa Bassuny ; Hedhli, Dorsaf ; Cérède, Odile ; Lebrun, Maryse ; Dimier-Poisson, Isabelle ; Mévélec, Marie-Noëlle</creator><creatorcontrib>Ismael, Alaa Bassuny ; Hedhli, Dorsaf ; Cérède, Odile ; Lebrun, Maryse ; Dimier-Poisson, Isabelle ; Mévélec, Marie-Noëlle</creatorcontrib><description>The present study was conducted mainly to evaluate the contribution of the cellular and the humoral responses in protection conferred by the MIC3 DNA vaccine (pMIC3i) that was proved as a potent vaccine against toxoplasmosis. We performed the adoptive transfer of CD4+and CD8+T lymphocytes from pMIC3i immunized mice to naive ones and the role of humoral immunity was evaluated byin vitroinvasion assays. We also constructed plasmids encoding the EGF-like domains and the Lectin-like domain of MIC3, to define which domains of MIC3 are involved in the protection. Furthermore, the adjuvant effect of the GM-CSF-expressing vector (granulocyte-macrophage colony-stimulating factor) required the precise temporal and spatial codelivery of GM-CSF with antigen, thus, we constructed a bicistronic plasmid expressing MIC3 and GM-CSF. In conclusion, the protection induced by pMIC3i was mainly mediated by CD4+and CD8+T lymphocytes and both EGF and Lectin domains of MIC3 conferred protection. Furthermore, the codelivery of GM-CSF by a bicistronic plasmid appeared to be a most effective way for enhancing the adjuvant properties of GM-CSF.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2009.02.107</identifier><language>eng</language><publisher>Kidlington: Elsevier Limited</publisher><subject>Antigens ; Brain ; Cysts ; Cytokines ; Deoxyribonucleic acid ; DNA ; Epidermal growth factor ; Experiments ; Immune system ; Immunization ; Infections ; Lectins ; Lymphocytes ; Medical research ; Proteins ; Toxoplasmosis ; Vaccines</subject><ispartof>Vaccine, 2009-05, Vol.27 (22), p.2959</ispartof><rights>Copyright Elsevier Limited May 14, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ismael, Alaa Bassuny</creatorcontrib><creatorcontrib>Hedhli, Dorsaf</creatorcontrib><creatorcontrib>Cérède, Odile</creatorcontrib><creatorcontrib>Lebrun, Maryse</creatorcontrib><creatorcontrib>Dimier-Poisson, Isabelle</creatorcontrib><creatorcontrib>Mévélec, Marie-Noëlle</creatorcontrib><title>Further analysis of protection induced by the MIC3 DNA vaccine againstT. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection</title><title>Vaccine</title><description>The present study was conducted mainly to evaluate the contribution of the cellular and the humoral responses in protection conferred by the MIC3 DNA vaccine (pMIC3i) that was proved as a potent vaccine against toxoplasmosis. We performed the adoptive transfer of CD4+and CD8+T lymphocytes from pMIC3i immunized mice to naive ones and the role of humoral immunity was evaluated byin vitroinvasion assays. We also constructed plasmids encoding the EGF-like domains and the Lectin-like domain of MIC3, to define which domains of MIC3 are involved in the protection. Furthermore, the adjuvant effect of the GM-CSF-expressing vector (granulocyte-macrophage colony-stimulating factor) required the precise temporal and spatial codelivery of GM-CSF with antigen, thus, we constructed a bicistronic plasmid expressing MIC3 and GM-CSF. In conclusion, the protection induced by pMIC3i was mainly mediated by CD4+and CD8+T lymphocytes and both EGF and Lectin domains of MIC3 conferred protection. Furthermore, the codelivery of GM-CSF by a bicistronic plasmid appeared to be a most effective way for enhancing the adjuvant properties of GM-CSF.</description><subject>Antigens</subject><subject>Brain</subject><subject>Cysts</subject><subject>Cytokines</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Epidermal growth factor</subject><subject>Experiments</subject><subject>Immune system</subject><subject>Immunization</subject><subject>Infections</subject><subject>Lectins</subject><subject>Lymphocytes</subject><subject>Medical research</subject><subject>Proteins</subject><subject>Toxoplasmosis</subject><subject>Vaccines</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqNkM1OwzAQhC0EEuHnEZBW4kqCnaSJyw2lDSABpxy4Va7jtA6pDbZTqc_MS-CEIoTEgdNoV7PfjBahC4Ijgkl23UZbxrlUIooxnkY49uv8AAWE5kkYTwg9RAGOszRMCX45RifWthjjSUKmAfooe-PWwgBTrNtZaUE38Ga0E9xJrUCquueihuUOvA2eHooEZs-3sE8EtmJSWVdFsNKqlvIGilnqYbVXChVw0XUWmBHj-Ya12oBoGk_XZsz6ixp-p_4UuYKldmt4HCYVdvJVjCHzu_JrqPVmKDIQRxrXqhHG_GKcoaOGdVac7_UUXZbzqrgPveW9F9YtWt0b_we7IBmhlOaZ_9L_XJ8OG3xT</recordid><startdate>20090514</startdate><enddate>20090514</enddate><creator>Ismael, Alaa Bassuny</creator><creator>Hedhli, Dorsaf</creator><creator>Cérède, Odile</creator><creator>Lebrun, Maryse</creator><creator>Dimier-Poisson, Isabelle</creator><creator>Mévélec, Marie-Noëlle</creator><general>Elsevier Limited</general><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20090514</creationdate><title>Further analysis of protection induced by the MIC3 DNA vaccine againstT. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection</title><author>Ismael, Alaa Bassuny ; Hedhli, Dorsaf ; Cérède, Odile ; Lebrun, Maryse ; Dimier-Poisson, Isabelle ; Mévélec, Marie-Noëlle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_16188876053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antigens</topic><topic>Brain</topic><topic>Cysts</topic><topic>Cytokines</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Epidermal growth factor</topic><topic>Experiments</topic><topic>Immune system</topic><topic>Immunization</topic><topic>Infections</topic><topic>Lectins</topic><topic>Lymphocytes</topic><topic>Medical research</topic><topic>Proteins</topic><topic>Toxoplasmosis</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ismael, Alaa Bassuny</creatorcontrib><creatorcontrib>Hedhli, Dorsaf</creatorcontrib><creatorcontrib>Cérède, Odile</creatorcontrib><creatorcontrib>Lebrun, Maryse</creatorcontrib><creatorcontrib>Dimier-Poisson, Isabelle</creatorcontrib><creatorcontrib>Mévélec, Marie-Noëlle</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (ProQuest Medical & Health Databases)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Family Health Database (Proquest)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Health Management Database (Proquest)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest_Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ismael, Alaa Bassuny</au><au>Hedhli, Dorsaf</au><au>Cérède, Odile</au><au>Lebrun, Maryse</au><au>Dimier-Poisson, Isabelle</au><au>Mévélec, Marie-Noëlle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Further analysis of protection induced by the MIC3 DNA vaccine againstT. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection</atitle><jtitle>Vaccine</jtitle><date>2009-05-14</date><risdate>2009</risdate><volume>27</volume><issue>22</issue><spage>2959</spage><pages>2959-</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>The present study was conducted mainly to evaluate the contribution of the cellular and the humoral responses in protection conferred by the MIC3 DNA vaccine (pMIC3i) that was proved as a potent vaccine against toxoplasmosis. We performed the adoptive transfer of CD4+and CD8+T lymphocytes from pMIC3i immunized mice to naive ones and the role of humoral immunity was evaluated byin vitroinvasion assays. We also constructed plasmids encoding the EGF-like domains and the Lectin-like domain of MIC3, to define which domains of MIC3 are involved in the protection. Furthermore, the adjuvant effect of the GM-CSF-expressing vector (granulocyte-macrophage colony-stimulating factor) required the precise temporal and spatial codelivery of GM-CSF with antigen, thus, we constructed a bicistronic plasmid expressing MIC3 and GM-CSF. In conclusion, the protection induced by pMIC3i was mainly mediated by CD4+and CD8+T lymphocytes and both EGF and Lectin domains of MIC3 conferred protection. Furthermore, the codelivery of GM-CSF by a bicistronic plasmid appeared to be a most effective way for enhancing the adjuvant properties of GM-CSF.</abstract><cop>Kidlington</cop><pub>Elsevier Limited</pub><doi>10.1016/j.vaccine.2009.02.107</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2009-05, Vol.27 (22), p.2959 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_journals_1618887605 |
source | ScienceDirect Freedom Collection |
subjects | Antigens Brain Cysts Cytokines Deoxyribonucleic acid DNA Epidermal growth factor Experiments Immune system Immunization Infections Lectins Lymphocytes Medical research Proteins Toxoplasmosis Vaccines |
title | Further analysis of protection induced by the MIC3 DNA vaccine againstT. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A57%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Further%20analysis%20of%20protection%20induced%20by%20the%20MIC3%20DNA%20vaccine%20againstT.%20gondii:%20CD4%20and%20CD8%20T%20cells%20are%20the%20major%20effectors%20of%20the%20MIC3%20DNA%20vaccine-induced%20protection,%20both%20Lectin-like%20and%20EGF-like%20domains%20of%20MIC3%20conferred%20protection&rft.jtitle=Vaccine&rft.au=Ismael,%20Alaa%20Bassuny&rft.date=2009-05-14&rft.volume=27&rft.issue=22&rft.spage=2959&rft.pages=2959-&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2009.02.107&rft_dat=%3Cproquest%3E3476861791%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_16188876053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1618887605&rft_id=info:pmid/&rfr_iscdi=true |